An interventional study of MBSR and MBWC in Late-Life Adults, Late-Life Prodromal Depression and Late-Life Depression, sponsored by National Health Research Institutes, Taiwan. Recruiting at 2 sites in Taiwan. Open to participants aged 55 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-16.
Sponsored by National Health Research Institutes, Taiwan · Not applicable, Interventional, and Health services research
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 166 studies in Depression with a site in Taiwan — 36 open to participants now, 43 under way, 3 of them phase 3. Depression · Taiwan.
Among the 166 studies in Depression with a site in Taiwan, this one is the 36th largest by planned enrollment of the 141 interventional ones that give a count, is one of 16 that started in 2025, is one of 118 with no phase, reaches primary completion later than 35 of the 42 other live ones, and was the 133rd registered.
8,608 studies on the registry are indexed under Depression; 1,736 are open to participants now.
Browse Depression studies →36 of the 166 studies in Depression with a site in Taiwan are open now. Recruiting first, the newest first:
Kaohsiung Medical University Chung-Ho Memorial Hospital · Sites in Taiwan
Ages 65+ · Healthy volunteers
National Yang Ming Chiao Tung University Hospital · Sites in Taiwan
Ages 40–90
Chang Gung Memorial Hospital · Sites in Taiwan
Ages 40+ · Healthy volunteers
Eli Lilly and Company · Sites in Taiwan, United States, Australia and 12 more countries
Ages 18–75
Chung Shan Medical University · Sites in Taiwan
Ages 18–65 · Healthy volunteers
A study can be open while its sites in Taiwan have not opened yet or have stopped. Only those recruiting at a site in Taiwan →
Of the 1,098 Depression studies recruiting now, 475 (43%) set no upper age limit and 522 (48%) stop at 75 or younger; 205 take children under 18; 315 take healthy volunteers.
This study: 55 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
166 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 7 · Phase 3 15 · Phase 4 3
First in 2004; this study’s year is marked. 16 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 124 is above the median of 81 across 7,089 interventional studies indexed under Depression.
Median enrollment 80 across the 141 interventional studies, 239 across the 24 observational. Of the 91 that completed or were terminated, 13 (14%) have results posted.
This tab as a report to print or save as PDF → With an account.
16 of 166 have an industry lead sponsor. The 10 most frequent:
National Health Research Institutes, Taiwan is the lead sponsor of 129 studies on the registry; 31 are open to participants now.
National Health Research Institutes, Taiwan has 3 studies filed under Depression — fewer than ten, so there is no comparison to draw.
15 of the studies in Depression with a site in Taiwan that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06854497Chiayi Christian HospitalThe Impact of Non-motor Symptom on the Outcome of Stroke Subjects | 2026-12-31 |
| NCT07604389Tungs' Taichung Metroharbour HospitalAR Health Education Video for Postoperative Breast Cancer Patients | 2026-12-31 |
| NCT06337773Fooyin UniversityDeveloping the Precision Nursing Education Program to Young Colorectal Cancer Survivors | 2027-01-13 |
| NCT06284551National Taiwan University HospitalThe Relationship Between Internet-use Behavior and Mental Health in Youth | 2027-01-24 |
| NCT06853106Taipei Medical UniversityDigital Sleep Program for College Students with Insomnia | 2027-02-28 |
Add all 15 to your calendar (.ics) → With an account.
Among the 166 studies in Depression with a site in Taiwan, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This randomized controlled trial will examine the effects of mindfulness-based interventions and brain stimulation interventions on cognitive function and psychological well-being in older adults. The study will employ a comprehensive assessment approach incorporating psychological evaluations, behavioral assessments, psychophysiological measurements, and neuroimaging analyses to characterize the outcome of nonpharmaceutical interventions in improving geriatric well-being or reducing depression severity.
Inclusion Criteria for individuals participating in mindfulness-based Interventions:
Exclusion Criteria for individuals participating in mindfulness-based Interventions:
Inclusion Criteria for individuals participating in brain stimulation Intervention:
Exclusion Criteria for individuals participating in brain stimulation Intervention:
Mindfulness-Based Stress Reduction
Behavioral: MBSR
Mindfulness-Based Well-Being Curriculum
Behavioral: MBWC
Mindfulness-Based Curriculum for Insomnia
Behavioral: MBCI
Brain Stimulation Intervention
Device: BSI
Mindfulness-Based Stress Reduction
Mindfulness-Based Well-Being Curriculum
Mindfulness-Based Curriculum for Insomnia
Brain Stimulation Intervention
Changes in neural activation related to emotional processing, sensory processing, attention, and memory-related brain regions.
Significant alterations in blood oxygen level-dependent (BOLD) signal amplitude during task-based functional magnetic resonance imaging (fMRI).
Time frame: Baseline assessment conducted during the 4-week period prior to intervention initiation; follow-up assessment conducted during the 4-week period following intervention completion.
Changes in resting-state functional connectivity within and between brain networks
Statistically significant alterations in intrinsic functional connectivity parameters derived from blood-oxygen-level-dependent (BOLD) signals acquired during resting-state functional magnetic resonance imaging (rs-fMRI).
Time frame: Baseline assessment conducted during the 4-week period prior to intervention initiation; follow-up assessment conducted during the 4-week period following intervention completion.
Regional brain morphometric changes, assessed by quantitative analysis of gray matter volume, thickness, and density differences using high-resolution structural magnetic resonance imaging.
Statistically significant alterations in regional gray matter volume (measured in cubic millimeters), thickness (measured in millimeters) or density (represented as a percentage between 0 and 1) compared to baseline measurements.
Time frame: Baseline assessment conducted during the 4-week period prior to intervention initiation; follow-up assessment conducted during the 4-week period following intervention completion.
Self-reported neuropsychological outcomes assessed through validated Wechsler Adult Intelligence Scale (WAIS).
Statistically significant changes across 3 time points using WAIS across subsets of facial memory test and (scores between 0 and 48), digit span in forward (scores between 0 and 16) and backward order (scores between 0 and 14), block design (scores between 0 and 68), digit symbol-coding (scores between 0 and 133).
Time frame: Baseline (within 4 weeks pre-intervention), immediate post-intervention (within 1 week of completion), and 1-month follow-up (within 1 week of the 1-month milestone).
Scores of the total number of category-naming items correctly named within one minute for testing verbal fluency.
Statistically significant changes across 3 time points using Verbal fluency scores in categories of colors, animals, cities, and fruits.
Time frame: Baseline (within 4 weeks pre-intervention), immediate post-intervention (within 1 week of completion), and 1-month follow-up (within 1 week of the 1-month milestone).
Changes in the depression scale
Depression scale changes measured by the geriatric depression scale (scores between 0 and 15) and the 17-item Hamilton depression rating scale (scores between 0 and 52) across 3 time points.
Time frame: Baseline (within 4 weeks pre-intervention), immediate post-intervention (within 1 week of completion), and 1-month follow-up (within 1 week of the 1-month milestone).
Changes in anxiety scale
Anxiety scale changes measured by the Hamilton anxiety rating scale (scores between 0 and 48) across 3 time points.
Time frame: Baseline (within 4 weeks pre-intervention), immediate post-intervention (within 1 week of completion), and 1-month follow-up (within 1 week of the 1-month milestone).
Changes in the loneliness scale
Changes of the loneliness scale developed by the University of California, Los Angeles, across 3 time points
Time frame: Baseline (within 4 weeks pre-intervention), immediate post-intervention (within 1 week of completion), and 1-month follow-up (within 1 week of the 1-month milestone).
Changes in perceived stress
Changes of the 14-item perceived stress scale (scores between 0 and 56) across 3 time points
Time frame: Baseline (within 4 weeks pre-intervention), immediate post-intervention (within 1 week of completion), and 1-month follow-up (within 1 week of the 1-month milestone).
Changes in the apathy scale
Changes of the 18-item apathy evaluation scale (scores between 0 and 72) across 3 time points
Time frame: Baseline (within 4 weeks pre-intervention), immediate post-intervention (within 1 week of completion), and 1-month follow-up (within 1 week of the 1-month milestone).
Changes in self-reported sleep outcomes assessed through sleepiness and sleep quality
Changes of the 3-item insomnia severity index for sleepiness (scores between 0 and 28) and the 10-item Pittsburgh Sleep Quality Index for sleep quality across 3 time points
Time frame: Baseline (within 4 weeks pre-intervention), immediate post-intervention (within 1 week of completion), and 1-month follow-up (within 1 week of the 1-month milestone).
Changes in self-reported intervention outcomes in terms of mindfulness, flourishing, and well-being
Changes of Intervention outcomes assessed by the 39-item five-facet mindfulness questionnaire, 30-item flourishing scale across 5 domains (mercifulness, playfulness, respectfulness, peacefulness, healthfulness), and two forms of well-being scale (short and long forms) across 3 time points. The short form is the World Health Organization-five well-being index (scores between 0 and 25). The long form is a 29-item well-being scale for the elderly in Taiwan (scores between 0 and 145).
Time frame: Baseline (within 4 weeks pre-intervention), immediate post-intervention (within 1 week of completion), and 1-month follow-up (within 1 week of the 1-month milestone).
Dynamic patterns of objective sleep parameters assessed through smart watch monitoring
Dynamic patterns of sleep indices (including sleep stage duration, sleep onset latency, and sleep efficiency), measured by a smart watch from baseline through to 1-month follow-up assessments.
Time frame: Continuous physiological monitoring conducted from 4 weeks pre-intervention through 4 weeks post-completion of the 1-month follow-up period (total monitoring duration: 16 weeks).
Dynamic patterns of objective cardiovascular parameters assessed through smart watch monitoring
Dynamic patterns of indices deriving from heart rate (including heart rate variability and stress), measured by a smart watch, from baseline through to 1-month follow-up assessments.
Time frame: Continuous physiological monitoring conducted from 4 weeks pre-intervention through 4 weeks post-completion of the 1-month follow-up period (total monitoring duration: 16 weeks).
Plan to share: No
No publications or documents are linked to this record.
Started Aug 2025 (actual). Primary completion is estimated for May 2028, 33 months after the start.
Of 3,486 non-industry interventional studies with no phase under Depression, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's planned 33 months is above that.
Counting every sponsor, half of 3,584 studies reached it within 21 months; a quarter within 9 and three quarters within 41.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
National Health Research Institutes, Taiwan →